Invention Grant
US06677435B2 Prodrug activation using catalytic antibodies 失效
使用催化抗体进行前药活化

Prodrug activation using catalytic antibodies
Abstract:
The present invention provides a compound that includes an active therapeutic agent attached to a blocking moiety that is sensitive to the catalytic action of molecules having retro-aldol and retro-Michael catalytic activity, methods for making such compounds and methods of converting such compounds to active therapeutic agents using molecules having aldolase activity.
Public/Granted literature
Information query
Patent Agency Ranking
0/0